Cargando…
Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study
Statins are currently the treatment of choice for hypercholesterolemia. However, wide interindividual variability has been observed in the response to treatment. Recent studies have reported the role of lncRNAs in the metabolism of lipids; nevertheless, there are few studies to date that show their...
Autores principales: | Paez, Isis, Prado, Yalena, Loren, Pía, Ubilla, Carmen G., Rodríguez, Nelia, Salazar, Luis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045917/ https://www.ncbi.nlm.nih.gov/pubmed/36979720 http://dx.doi.org/10.3390/biomedicines11030742 |
Ejemplares similares
-
Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study
por: Paez, Isis, et al.
Publicado: (2020) -
MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
por: Ubilla, Carmen Gloria, et al.
Publicado: (2021) -
MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy
por: Saavedra, Kathleen, et al.
Publicado: (2022) -
SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals
por: Prado, Yalena, et al.
Publicado: (2015) -
Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021)